pharmeasy: Goldman Sachs likely to invest Rs 2,700 crore in PharmEasy parent
Goldman Sachs is in advanced talks to invest about $350 million (Rs 2,700 crore) in API Holdings, the parent of online pharmacy PharmEasy, in a structured debt transaction, people in…
Read More...
Read More...